logo
Sign in

SZLS Stock Price, Chart, Stats & News

StageZero Life Sciences Ltd.
Save

StageZero Life Sciences Ltd. (SZLS) does not currently pay a dividend.

4.94M
Market cap
Current P/E
3.37x
Forward P/E

SZLS chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Medical - Diagnostics & Research
Industry

StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise specializing in the development and market release of advanced molecular diagnostic tests. These innovative solutions are designed for the proactive detection of diseases and individualized health management, with a particular emphasis on oncology-related conditions across North America. Central to its operations is the proprietary Sentinel Principle platform, which enables the identification of novel biomarkers directly from whole blood samples.

Similar securities

Based on sector and market capitalization

Report issue